tiprankstipranks
Advertisement
Advertisement
Esperion Stock Surges Onto Analysts’ Trending Radar
PremiumWeekend UpdatesEsperion Stock Surges Onto Analysts’ Trending Radar
20d ago
Esperion downgraded to Hold from Buy at Jefferies
Premium
The Fly
Esperion downgraded to Hold from Buy at Jefferies
20d ago
Esperion downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
Esperion downgraded to Neutral from Overweight at Piper Sandler
20d ago
Esperion to be acquired by Archimed for $3.16 per share, one CVR
PremiumThe FlyEsperion to be acquired by Archimed for $3.16 per share, one CVR
20d ago
Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
Premium
Ratings
Esperion Therapeutics: Reinforced Buy Rating on Strengthened Investment Story and Conference-Driven Upside Catalysts
1M ago
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
Premium
Company Announcements
Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio
2M ago
Esperion management to meet with Piper Sandler
PremiumThe FlyEsperion management to meet with Piper Sandler
2M ago
Esperion says bempedoic acid receives recommendations in ACC/AHA Guideline
Premium
The Fly
Esperion says bempedoic acid receives recommendations in ACC/AHA Guideline
2M ago
Esperion price target raised to $5 from $4 at Citizens
Premium
The Fly
Esperion price target raised to $5 from $4 at Citizens
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100